F. KAYHAN Et Al. , "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.," Diabetes Metab Syndr. , vol.7, no.1, pp.12-16, 2013
KAYHAN, F. Et Al. 2013. Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.. Diabetes Metab Syndr. , vol.7, no.1 , 12-16.
KAYHAN, F., Koldemir-Gündüz, M., ÇAĞATAY, P., Ciftci, C., & Susleyici Duman, B., (2013). Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.. Diabetes Metab Syndr. , vol.7, no.1, 12-16.
KAYHAN, FE. Et Al. "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.," Diabetes Metab Syndr. , vol.7, no.1, 12-16, 2013
KAYHAN, FE. Et Al. "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.." Diabetes Metab Syndr. , vol.7, no.1, pp.12-16, 2013
KAYHAN, F. Et Al. (2013) . "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.." Diabetes Metab Syndr. , vol.7, no.1, pp.12-16.
@article{article, author={FE. KAYHAN Et Al. }, title={Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension.Diabetes Metab Syndr.}, journal={Diabetes Metab Syndr.}, year=2013, pages={12-16} }